Bulletin
Investor Alert

New York Markets Open in:

×

CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201917619/composite

$

6.45

Change

+0.02 +0.31%

Volume

Volume 7,403

Jul 18, 2019, 5:27 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201917619/composite

Previous close

$ 6.39

$ 6.43

Change

+0.04 +0.63%

Day low

Day high

$6.16

$6.45

Open
Open: 6.39

52 week low

52 week high

$4.82

$14.00

Open

Market cap

$438.97M

Average volume

1.56M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.34

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cbay

MarketWatch News on CBAY

  1. CymaBay Therapeutics started at buy with $14 stock price target at Stifel Nicolaus

    7:45 a.m. June 25, 2019

    - Tomi Kilgore

  2. CymaBay Therapeutics stock price target cut to $7 from $11 at B. Riley FBR

    12:15 p.m. June 17, 2019

    - Tomi Kilgore

  3. CymaBay Therapeutics upgraded to strong buy from market outperform at Raymond James

    7:27 a.m. June 12, 2019

    - Tomi Kilgore

  4. CymaBay Therapeutics started at neutral with $9 stock price target at B. Riley FBR

    10:08 a.m. Feb. 6, 2019

    - Tomi Kilgore

  5. CymaBay Therapeutics reiterated as buy at SunTrust Robinson Humphrey

    8:46 a.m. Dec. 31, 2018

    - Ciara Linnane

  6. 4 charts to watch as tech stocks rebound

    12:18 p.m. Feb. 14, 2018

    - Harry Boxer

  7. CymaBay Therapeutics started at outperform with $35 stock price target at Evercore ISI

    8:40 a.m. Feb. 13, 2018

    - Tomi Kilgore

  8. Harry Boxer’s momentum stocks to watch this week

    11:12 a.m. Oct. 25, 2017

    - Harry Boxer

  9. CymaBay Therapeutics started at buy with $15 stock price target at SunTrust RH

    7:35 a.m. Aug. 18, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/cbay

Other News on CBAY

  1. Eli Lilly And Baricitinib In PBC: What's The Story?

    3:47 p.m. July 10, 2019

    - Seeking Alpha

  2. Stifel likes Viking Therapeutics in premarket analyst action

    8:25 a.m. June 25, 2019

    - Seeking Alpha

  3. CymaBay +2.8% on new Buy rating at Stifel

    5:20 p.m. June 24, 2019

    - Seeking Alpha

  4. CymaBay Therapeutics (CBAY) Gets a Buy Rating from H.C. Wainwright

    12:22 p.m. June 12, 2019

    - SmarterAnalyst

  5. SYBX, MAT among premarket gainers

    9:16 a.m. June 12, 2019

    - Seeking Alpha

  6. CymaBay +4.8% as Raymond James fades 45% sell-off

    5:32 p.m. June 11, 2019

    - Seeking Alpha

  7. Healthcare tops midday movers

    12:41 p.m. June 11, 2019

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/cbay

Press Releases on CBAY

  1. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.